Parr Mcknight Wealth Management Group, LLC Gilead Sciences, Inc. Transaction History
Parr Mcknight Wealth Management Group, LLC
- $762 Billion
- Q3 2025
A detailed history of Parr Mcknight Wealth Management Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Parr Mcknight Wealth Management Group, LLC holds 2,121 shares of GILD stock, worth $263,194. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,121
Previous 2,121
-0.0%
Holding current value
$263,194
Previous $235 Million
0.12%
% of portfolio
0.03%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
2,406Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Vanguard Group Inc Valley Forge, PA121MShares$15 Billion0.23% of portfolio
-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...